← Back to Screener
Progyny, Inc. Common Stock (PGNY)
Price$18.64
Favorite Metrics
Price vs S&P 500 (26W)-18.60%
Price vs S&P 500 (4W)-9.55%
Market Capitalization$1.42B
P/E Ratio (Annual)24.25x
All Metrics
P/CF (Annual)6.75x
Book Value / Share (Quarterly)$6.19
P/TBV (Annual)4.34x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)17.87%
Cash Flow / Share (Quarterly)$2.30
Price vs S&P 500 (YTD)-33.58%
Gross Margin (TTM)23.63%
Net Profit Margin (TTM)4.54%
EPS (TTM)$0.65
10-Day Avg Trading Volume1.34M
EPS Excl Extra (TTM)$0.65
Revenue Growth (5Y)30.16%
EPS (Annual)$0.65
ROI (Annual)11.34%
Gross Margin (Annual)23.63%
Net Profit Margin (5Y Avg)6.38%
Cash / Share (Quarterly)$3.72
P/E Basic Excl Extra (TTM)24.25x
Revenue Growth QoQ (YoY)6.69%
EPS Growth (5Y)6.78%
P/E Normalized (Annual)24.25x
ROA (Last FY)7.88%
Revenue Growth TTM (YoY)10.40%
EBITD / Share (TTM)$1.01
ROE (5Y Avg)13.92%
Operating Margin (TTM)6.62%
Cash Flow / Share (Annual)$2.30
P/B Ratio2.75x
P/B Ratio (Quarterly)4.29x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.01x
Net Interest Coverage (TTM)-85.00x
ROA (TTM)7.73%
EPS Growth QoQ (YoY)24.78%
EV / EBITDA (TTM)14.49x
EPS Incl Extra (Annual)$0.65
Current Ratio (Annual)2.73x
Quick Ratio (Quarterly)2.62x
3-Month Avg Trading Volume1.49M
52-Week Price Return-15.33%
EV / Free Cash Flow (Annual)6.82x
P/E Incl Extra (TTM)24.25x
Revenue / Employee (TTM)$2
Tangible BV / Share (Quarterly)$6.12
P/S Ratio (Annual)1.10x
Asset Turnover (Annual)1.74x
52-Week High$28.75
Operating Margin (5Y Avg)5.50%
EPS Excl Extra (Annual)$0.65
CapEx CAGR (5Y)77.67%
Tangible BV CAGR (5Y)25.20%
26-Week Price Return-9.85%
Quick Ratio (Annual)2.62x
13-Week Price Return-30.63%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)2.73x
Enterprise Value$1,307.084
Revenue / Share Growth (5Y)32.74%
Asset Turnover (TTM)1.70x
Book Value / Share Growth (5Y)26.43%
Revenue / Employee (Annual)$2
Pretax Margin (Annual)7.41%
Cash / Share (Annual)$3.72
3-Month Return Std Dev52.34%
Gross Margin (5Y Avg)22.19%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)53.73%
EBITDA Interim CAGR (5Y)61.71%
ROE (Last FY)11.34%
EPS Basic Excl Extra (Annual)$0.65
P/FCF (TTM)7.40x
Receivables Turnover (TTM)5.66x
EV / Free Cash Flow (TTM)6.82x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$0.65
Receivables Turnover (Annual)5.66x
ROI (TTM)11.37%
P/S Ratio (TTM)1.10x
Pretax Margin (5Y Avg)6.12%
Revenue / Share (Annual)$14.34
Tangible BV / Share (Annual)$6.12
Forward P/E15.95x
Free OCF CAGR (5Y)40.40%
Price vs S&P 500 (52W)-50.42%
P/E Ratio (TTM)24.25x
EPS Growth TTM (YoY)16.84%
Year-to-Date Return-29.44%
5-Day Price Return6.71%
EPS Normalized (Annual)$0.65
ROA (5Y Avg)9.80%
Net Profit Margin (Annual)4.54%
Month-to-Date Return6.71%
Cash Flow / Share (TTM)$0.54
EBITD / Share (Annual)$1.00
EPS Growth (3Y)28.91%
Operating Margin (Annual)6.62%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)6.75x
ROI (5Y Avg)13.92%
P/E Excl Extra (TTM)24.25x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$0.65
P/TBV (Quarterly)4.34x
P/B Ratio (Annual)4.29x
Pretax Margin (TTM)7.41%
Book Value / Share (Annual)$6.19
Price vs S&P 500 (13W)-33.49%
Net Margin Growth (5Y)-19.56%
Beta0.91x
P/FCF (Annual)7.40x
Revenue / Share (TTM)$14.35
ROE (TTM)11.37%
52-Week Low$16.10
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.06
4.18
4.18
4.18
Industry Peers — Health Services(14)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
PGNYProgyny, Inc. Common Stock | 24.25x | 10.40% | 6.62% | 11.37% | $18.64 |
FMSFresenius Medical Care AG | 11.75x | 1.51% | 9.31% | 7.26% | $23.18 |
DVADaVita Inc. | 13.37x | 6.46% | 14.88% | 181.22% | $149.33 |
SHCSotera Health Company Common Stock | 59.47x | 5.74% | 25.41% | 14.98% | $16.28 |
AGLagilon health, inc. | — | -2.11% | -7.81% | -116.65% | $28.30 |
MCTACharming Medical Limited Class A Ordinary Shares | 414.66x | — | 15.45% | — | $29.36 |
VMDViemed Healthcare, Inc. Common Shares | 24.97x | 20.52% | 8.49% | 10.87% | $9.66 |
QIPTQuipt Home Medical Corp. Ordinary Shares | — | 9.52% | -1.22% | -10.47% | $3.65 |
PARKPark Dental Partners, Inc. Common Stock | 17.91x | — | 0.10% | — | $18.25 |
OAKUOak Woods Acquisition Corporation Class A Ordinary Shares | 174.54x | — | — | -0.64% | $12.20 |
OAKUROak Woods Acquisition Corporation Right | 174.54x | — | — | -0.64% | $0.16 |
About
Progyny provides fertility, family building, and women's health benefits management solutions to employers. The company operates an integrated platform called Smart Cycles that combines treatment services, access to a curated network of high-quality fertility specialists, and active management of a selective provider network to deliver comprehensive reproductive health benefits.